Stockreport

IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026 [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF LAWRENCEVILLE, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN Dear Valued Shareholders, 2025, A Year of Momentum: Advancing Toward a Potential [Read more]